Eshwar Thirunavukkarasu

Eshwar Thirunavukkarasu

Auto-generated profile, based on publicly available information

Eshwar Thirunavukkarasu

Department of Internal Medicine, University of Michigan Medical School, 109 Zina Pitcher Dr., Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2011 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
BRBradley J Rabquer
Bradley J Rabquer
ETEliza Pei-Suen Tsou
Eliza Pei-Suen Tsou
YHYong Hou
Yong Hou
ETEshwar Thirunavukkarasu
Eshwar Thirunavukkarasu
GHG Kenneth Haines
G Kenneth Haines
AKAlisa E Koch
Alisa E Koch
Systemic sclerosis (SSc) is characterized by fibrosis and microvascular abnormalities including dysregulated angiogenesis. Chemokines, in addition to their chemoattractant properties, have the ability to modulate angiogenesis. Chemokines lacking the enzyme-linked receptor (ELR) motif, such as monokine induced by interferon-γ (IFN-γ) (MIG/CXCL9) and IFN-inducible protein 10 (IP-10/CXCL10), inhibit angiogenesis by binding CXCR3. In addition, CXCL16 promotes angiogenesis by binding its unique receptor CXCR6. In this study, we determined the expression of these chemokines and receptors in SSc skin and serum.